A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently With Radiation Therapy and Radiation Therapy Alone for Women With HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy NSABP-43
A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women With Node- Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer NSABP-47
A PHASE III CLINICAL TRIAL COMPARING THE COMBINATION OF DOCETAXEL PLUS CYCLOPHOSPHAMIDE TO ANTRHRACYCLINE-BASED CHEMOTHERAPY REGIMENS FOR WOMEN WITH NODE-POSITIVE OR HIGH-RISK NODE-NEGATIVE, HER-2 NEGATIVE BREAST CANCER NSABP B49
Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost vs. Standard Whole Breast Irradiation Plus Sequential Boost for Early Stage Breast Cancer RTOG 1005
PHASE II PLACEBO-CONTROLLED TRIAL OF LISINOPRIL AND COREG CRŽ TO REDUCE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER RECEIVING (NEO) ADJUVANT CHEMOTHERAPY WITH TRASTUZUMAB (HERCEPTINŽ) SCUSF 0806
